RESULTS OF 96-WEEK FOLLOW-UP AFTER DISCONTINUATION OF NUCLEOS(T)IDE ANALOGUE THERAPY IN CHRONIC HEPATITIS B GENOTYPE D REGION (NUCSTOP STUDY)

被引：0
|
作者：
Kiremitci, Sercan
Seven, Gulseren
Keskin, Elmas Biberci
Koker, Ibrahim H.
Kochan, Koray
Senturk, Hakan
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1520
引用
收藏
页码：S1361 / S1361
页数：1
相关论文
共 50 条
  • [31] Predictors for efficacy of combination therapy with a nucleos(t)ide analogue and interferon for chronic hepatitis B
    Hong Li
    Hua Wang
    Cheng Peng
    Xin Zheng
    Jia Liu
    Zhi-hong Weng
    Dong-liang Yang
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2017, 37 : 547 - 555
  • [32] Antiviral effect of entecavir in nucleos(t)ide analogue-naive and nucleos(t)ide analogue- experienced chronic hepatitis B patients without virological response at week 24 or 48 of therapy
    Chen, Chien-Hung
    Hu, Tsung-Hui
    Hung, Chao-Hung
    Wang, Jing-Houng
    Lu, Sheng-Nan
    Lee, Chuan-Mo
    JOURNAL OF VIRAL HEPATITIS, 2014, 21 (08) : E55 - E64
  • [33] The Safety and Efficacy of Entecavir and Tenofovir Combination Therapy for Chronic Hepatitis B in Patients with Previous Nucleos(t)ide Treatment Failure: Week 96 Results of the ENTEBE study
    Zoulim, Fabien
    Jablkowski, Maciej S.
    Diculescu, Mircea.
    Petersen, Joerg
    Marcellin, Patrick
    Bendahmane, Soumaya
    Kedzierska, Aleksandra
    Simon, Krzysztof
    Janssen, Harry L.
    HEPATOLOGY, 2014, 60 : 314A - 315A
  • [34] Long-term outcomes after nucleos(t)ide analogue discontinuation in HBeAg-positive chronic hepatitis B patients
    He, D.
    Guo, S.
    Zhu, P.
    Tao, S.
    Li, M.
    Huang, H.
    Wang, J.
    Wang, Y.
    Ding, M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (10) : O687 - O693
  • [35] Current practice and contrasting views on discontinuation of nucleos(t)ide analog therapy in chronic hepatitis B
    Hadziyannis, Emilia
    Hadziyannis, Stephanos
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 14 (04) : 243 - 251
  • [36] Tenofovir rescue therapy after multiple nucleos(t)ide analogue treatment failure in chronic hepatitis B patients
    Kim, Hyo Jin
    Cho, Ju-Yeon
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Koh, Kwang Cheol
    Paik, Seung Woon
    Yoo, Byung Chul
    Lee, Joon Hyeok
    HEPATOLOGY, 2013, 58 : 638A - 638A
  • [37] Factors associated with adherence to nucleos(t)ide analogs in chronic hepatitis B patients: results from a 1-year follow-up study
    Peng, Jie
    Yin, Junhua
    Cai, Shaohang
    Zhong, Chunxiu
    PATIENT PREFERENCE AND ADHERENCE, 2015, 9 : 41 - 45
  • [38] Keystone to Secure Safety After Stopping Nucleos(t)ide Analogue Therapy in Chronic Hepatitis B Patients Reply
    Hsu, Yao-Chun
    Tseng, Cheng-Hao
    Nguyen, Mindie H.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (08) : 1891 - 1892
  • [39] HBsAg decline after interrupting nucleos(t)ide analogue therapy in HVeAg-negative chronic hepatitis B
    Siederdissen, C. Hoener zu
    Rinker, F.
    Falk, C. S.
    Filmann, N.
    Maasoumy, B.
    Deterding, K.
    Port, K.
    Mix, C.
    Herrmann, E.
    Wedemeyer, H.
    Manns, M. P.
    Kraft, A. R. M.
    Cornberg, M.
    JOURNAL OF CLINICAL VIROLOGY, 2015, 69 : 233 - 233
  • [40] Effect of Nucleos(t)ide Analogue Therapy on Risk of Intrahepatic Cholangiocarcinoma in Patients With Chronic Hepatitis B
    Lee, Teng-Yu
    Hsu, Yao-Chun
    Yu, Shi-Hang
    Lin, Jaw-Town
    Wu, Ming-Shiang
    Wu, Chun-Ying
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (06) : 947 - +
12345